Christopher Counter

George Barth Geller Distinguished Professor of Pharmacology
Christopher Counter
Christopher Counter

Overview

The Counter lab studies the molecular mechanisms that underly to the onset of human cancers, with the goal to prevent cancer initiation or progression.  The lab uses ultra-senstitive sequencing platforms and proteomic-coupled CRISPR/Cas9 screens to elucidate the factors that mold the mutational patterns selected to initiate the process of tumorigenesis.  See https://counter.labs.duke.edu/ for further details.

Positions

George Barth Geller Distinguished Professor of Pharmacology in the School of Medicine

2021 School of Medicine

Professor of Pharmacology and Cancer Biology in the School of Medicine

2011 School of Medicine

Assistant Professor in Radiation Oncology in the School of Medicine

2020 School of Medicine

Professor of Cell Biology in the School of Medicine

2022 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2002 School of Medicine

Education

B.S. 1990

1990 McMaster University (Canada)

Ph.D. 1996

1996 McMaster University (Canada)

Postdoctoral Fellow, Whitehead Institute For Biomedical Research

1998 Massachusetts Institute of Technology

Publications, Grants & Awards

Offices & Contact

C225 Lev Sci Res Ctr
Durham, NC
27708
Duke Box 3813
Durham, NC
27710